SCHEMBL18847289

SCHEMBL18847289

c1ccc(-c2nc3ccccc3c3c2ccc2c4ccccc4n(-c4ccc(-c5cccc(-n6c7ccccc7c7ccccc76)c5)cc4)c23)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.40
▸ KDM4E B2RXH2 2/20 0.40
▸ ATM Q13315 1/20 0.40
▸ MEN1 O00255 4/20 0.37
▸ KMT2A Q03164 4/20 0.37
▸ GAA P10253 2/20 0.37
▸ PDE10A Q9Y233 1/20 0.36
▸ DHODH Q02127 2/20 0.35
▸ ALDH1A1 P00352 4/20 0.35
▸ LMNA P02545 1/20 0.35
▸ MAPT P10636 4/20 0.34
▸ HSP90AA1 P07900 1/20 0.34
▸ HSD17B10 Q99714 2/20 0.33
▸ ESR1 P03372 1/20 0.33
▸ ESR2 Q92731 1/20 0.33
▸ IL1R1 P14778 1/20 0.33
▸ HDAC4 P56524 1/20 0.33
▸ USP2 O75604 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18846733 0.99 KDM4E (0.41) L3MBTL1KDM4EATMMEN1KMT2A
SCHEMBL18847731 0.95 KDM4E (0.41) L3MBTL1KDM4EATMMEN1KMT2A
SCHEMBL18847266 0.94 KDM4E (0.39) L3MBTL1KDM4EATMMEN1KMT2A
SCHEMBL18847211 0.93 KDM4E (0.40) L3MBTL1KDM4EATMMEN1KMT2A
SCHEMBL18847141 0.93 L3MBTL1 (0.42) L3MBTL1KDM4EATMMEN1KMT2A
SCHEMBL18847217 0.92 KDM4E (0.38) L3MBTL1KDM4EATMMEN1KMT2A
SCHEMBL18847298 0.92 GAA (0.38) L3MBTL1KDM4EATMMEN1KMT2A
SCHEMBL18847291 0.92 GAA (0.38) L3MBTL1KDM4EATMMEN1KMT2A
SCHEMBL18847571 0.92 ESR1 (0.46) KDM4EMEN1KMT2AGAAALDH1A1
SCHEMBL18846712 0.91 L3MBTL1 (0.40) L3MBTL1KDM4EATMMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10446765-B2 Heterocyclic compound and organic light emitting element using same HEESUNG MATERIAL LTD. (KR) 2019-10-15 — — US disclosed
US-20170133602-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME HEESUNG MATERIAL LTD. (KR) 2017-05-11 — — US disclosed
US-20170133602-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME HEESUNG MATERIAL LTD. (KR) 2017-05-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170133602-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME CRY1, CRY2, PER2 L3MBTL1 995/4885KDM4E 1869/4885ATM 3417/4885
US-10446765-B2 Heterocyclic compound and organic light emitting element using same CRY1, CRY2, PER2 L3MBTL1 995/4885KDM4E 1869/4885ATM 3417/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback